top of page
Optimizing Personalized Dosimetry for Y90 Radioembolization with Dr. Russell Reeves, Dr. Shamar Young, Dr. Venkatesh Krishnasamy on the BackTable VI Podcast
00:00 / 01:04
loading.gif

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 3  •  17 Jan 2025

Optimizing Personalized Dosimetry for Y90 Radioembolization

Y90 radioembolization is not a TACE-like procedure. “It's just not. It is a radiation procedure,” says Dr. Shamar Young, and that means the dose each tumor receives, including the dose reaching its coldest 5% (D95), drives both outcomes and side effects. On this episode of the BackTable Podcast, interventional radiologist Dr. Kavi Krishnasamy talks with Dr. Young, interventional radiologist at the University of Arizona and CEO of TeleDaaS, and Dr. Russell Reeves, the only interventional radiologist at Samaritan Medical Center in upstate New York, about what personalized dosimetry really means in 2026, from D95, V400, and dose-volume histograms to single-compartment, partition, and voxel-based methods, lung shunt estimates with planar imaging versus SPECT/CT, and the value of post-treatment dosimetry.

This podcast is supported by

TeleDaaS

Timestamps

00:00 - Introduction
02:17 - Choosing Liver-Directed Therapy
08:05 - Bringing Advanced Dosimetry to Community Practice
09:36 - D95, V400, and Defining Personalized Dosimetry
24:57 - Dosimetry Without Software
29:02 - Mapping, Lung Shunt, and Post-Treatment Dosimetry
40:38 - Single-Session Y90
42:50 - Coding and Documentation for Dosimetry
48:59 - Who Should Do the Dosimetry?
58:26 - Setting Up Outsourced Dosimetry
1:01:55 - Why Interventional Radiologists Struggle to Outsource
1:10:37 - Cases: Large HCC and Metastatic Breast Cancer
1:26:45 - Closing Remarks

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

Running a Y90 program with advanced dosimetry is possible even for a solo interventional radiologist two years out of training, and Dr. Russell Reeves describes how he does it at a 220-bed community hospital. The three physicians compare in-house software, radiation oncology, core labs, and outsourced dosimetry as a service, explain how to document dosimetry so it is coded correctly, and discuss why interventional radiologists have been slow to outsource. Dr. Reeves closes with two cases, a large hepatocellular carcinoma with tumor in the vein and metastatic breast cancer after prior liver SBRT, that show how dose planning sets the limits of treatment.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page